Hematological Disorders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hematological Disorders Pipeline Market Report Overview

Hematological disorders include hematology tests and hemostasis test segments. Hemostasis tests help screen and identify patients with hemostatic defects. Hematology tests include various blood tests that help diagnose and monitor various conditions.

The hematological disorders pipeline market research report covers comprehensive information about the hematological disorders pipeline products with a comparative analysis of the products at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Segments ·       Coagulation Analyzers

·       Hemostasis Tests

·       Special Coagulation Tests

·       General Coagulation Tests

·       Hematology Tests

Key Territories ·       The US

·       Europe

·       China

·       Australia

·       South Korea

Key Regulatory Paths ·       510(k)

·       CE-IVD

·       NMPA

·       CE

·       TGA

Leading Companies ·       Abionic SA

·       Abram Scientific Inc

·       Analyticon Biotechnologies AG

·       Aptitude Medical Systems Inc

·       Atantares Corp

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hematological Disorders Pipeline Market Segments

The key segments in the hematological disorders pipeline market are Coagulation Analyzers, Hemostasis Tests, Special Coagulation Tests, General Coagulation Tests, and Hematology Tests among others. As of October 2024, both coagulation analyzers and hemostasis tests account for the highest number of pipeline products.

Hematological Disorders Pipeline Market Analysis by Segments, 2024 (%)

Hematological Disorders Pipeline Market Analysis by Segments, 2024 (%)

Buy the Full Report for More Segmental Insights into the Hematological Disorders Pipeline Market

Download a Free Report Sample

Hematological Disorders Pipeline Market Segmentation by Territories

The key territories in the hematological disorders pipeline market are the US, Europe, China, Australia, and South Korea, among others. As of October 2024, the US accounts for the highest number of pipeline products.

Hematological Disorders Pipeline Market Analysis by Territories, 2024 (%)

Hematological Disorders Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Hematological Disorders Pipeline Market

Download a Free Report Sample

Hematological Disorders Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the hematological disorders pipeline products market are 510(k), CE-IVD, NMPA, CE, and TGA. As of October 2024, 510(k) is the most followed pathway for pipeline products in the hematological disorders market.

Hematological Disorders Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Hematological Disorders Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Hematological Disorders Pipeline Market

Download a Free Report Sample

Hematological Disorders Pipeline Market – Competitive Landscape

A few of the leading companies associated with the hematological disorders pipeline market are:

  • Abionic SA
  • Abram Scientific Inc
  • Analyticon Biotechnologies AG
  • Aptitude Medical Systems Inc
  • Atantares Corp

Abionic SA (Abionic): Headquartered in Lausanne, Waadt, Switzerland, it is a medical device company that develops, produces, and markets in vitro diagnostic devices. The company provides products such as abioSCOPE, IVD capsule, abioGUIDE, abioGUIDE application for Android, iPhone, and iPad, and accessories, among others. The company’s IVD capsule test offers accurate information about patients’ respiratory allergies from a drop of blood. Its AbioGUIDE offers access to a complete database, showing cross-reactions with other allergens, as well as illustrations.

Abram Scientific Inc (Abram Scientific): The company provides fast point-of-care (POC) coagulation diagnostics for hemostasis management. Abram Scientific is headquartered in San Francisco, California, the US.

Hematological Disorders Pipeline Market Analysis by Companies, 2024

Hematological Disorders Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Hematological Disorders Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Hematological Disorders Pipeline Market Segments Outlook (2024)

  • Coagulation Analyzers
  • Hemostasis Tests
  • Special Coagulation Tests
  • General Coagulation Tests
  • Hematology Tests


Hematological Disorders Pipeline Market Territories Outlook (2024)

  • The US
  • Europe
  • China
  • Australia
  • South Korea

Hematological Disorders Pipeline Market Regulatory Paths Outlook (2024)

  • 510(k)
  • CE-IVD
  • NMPA
  • CE
  • TGA

Scope

This report provides:

  • An extensive coverage of the hematological disorders under development.
  • Details of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.
  • Reviews of major players involved in the development of hematological disorders and lists of all their pipeline projects.
  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
  • Key clinical trial data of ongoing clinical trials specific to pipeline products.
  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.
  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain competitive advantage.
  • Identify and understand important and diverse types of hematological disorders under development.
  • Develop market-entry and market-expansion strategies.
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Abionic SA
Abram Scientific Inc
Analyticon Biotechnologies AG
Aptitude Medical Systems Inc
Atantares Corp
Atomo Diagnostics Ltd
Baebies Inc
Beckman Coulter Inc
Beijing Sailing Medical Technology Co Ltd
Bio Vitos Pharma AB
Biochip Labs Inc
BioMedica USA LLC (Inactive)
BioMedomics Inc
Biosurfit, SA
Braun Biosystems, Inc. (Inactive)
Carclo Diagnostic Solutions Ltd
Coramed Technologies, LLC
Diagnostica Stago Inc
Duke University
DxDiscovery Inc
Dynasil Corporation of America
Edan Instruments Inc
EKF Diagnostics Holdings Plc
ELITechGroup Inc
Emosis SAS
Epimune GmbH
Epinex Diagnostics Inc
ET Healthcare Inc
Flobio LLC
Fraunhofer Institute for Cell Therapy and Immunology
genedrive plc
Grifols SA
Group K Diagnostics
Guangzhou Wondfo Biotech Co Ltd
Hansjorg Wyss Institute for Biologically Inspired Engineering
Helena Laboratories Corp
Hemex Health Inc
HemoSonics LLC
Immunostep S.L
Instrumentation Laboratory Co (Inactive)
IntraMed Diagnostics, LLC
Inverness Medical Canada Inc. (Inactive)
Levisonics Inc
Massachusetts General Hospital
McMaster University
MiCo BioMed Co Ltd
Novametics Inc (Inactive)
Ohio State University
Optolane Technologies Inc
Pakwa Technologies
Perosphere Technologies Inc
PortaScience Inc
Prolight Diagnostics AB
QSTAG Co Ltd
Radiometer Medical ApS
Randox Laboratories Ltd
Rappaport Family Institute for Research in the Medical Science
Retham Technologies LLC
rHealth
Roche Diagnostics International Ltd
Sanguina LLC
Sekisui Diagnostics LLC
ShanMukha Innovations Pvt Ltd
Siemens Healthcare Diagnostics GmbH
Siemens Healthcare Diagnostics Inc
Siemens Healthineers AG
Silver Lake Research Corporation
SonoMedix, Inc.
SpinChip Diagnostics AS
SQI Diagnostics Inc
Stichting Lygature
T2 Biosystems Inc
The Binding Site Group Ltd
ThromboTherapeutics Inc
Tosoh Bioscience Inc
Transfusion & Transplantation Technologies (Inactive)
Universal Biosensors Inc
University of Burdwan
University of California Irvine
University of Colorado
University of Colorado Anschutz Medical Campus
University of Melbourne
University of Michigan
University of Texas Health Science Center at Houston
University of Vermont
University of Washington
VitaMe Technologies Inc

Table of Contents

|1 Table of Contents

|1.1 List of Tables

|1.2 List of Figures

2 Introduction

2.1 Hematological Disorders Overview

3 Products under Development

3.1 Hematological Disorders – Pipeline Products by Stage of Development

3.2 Hematological Disorders – Pipeline Products by Segment

3.3 Hematological Disorders – Pipeline Products by Territory

3.4 Hematological Disorders – Pipeline Products by Regulatory Path

3.5 Hematological Disorders – Pipeline Products by Estimated Approval Date

3.6 Hematological Disorders – Ongoing Clinical Trials

4 Hematological Disorders – Pipeline Products under Development by Companies

4.1 Hematological Disorders Companies – Pipeline Products by Stage of Development

4.2 Hematological Disorders – Pipeline Products by Stage of Development

5 Hematological Disorders Companies and Product Overview

5.1 Abionic SA Company Overview

5.1.1 Abionic SA Pipeline Products & Ongoing Clinical Trials Overview

5.2 Abram Scientific Inc Company Overview

5.2.1 Abram Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

5.3 Analyticon Biotechnologies AG Company Overview

5.3.1 Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview

5.4 Aptitude Medical Systems Inc Company Overview

5.4.1 Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.5 Atantares Corp Company Overview

5.5.1 Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview

5.6 Atomo Diagnostics Ltd Company Overview

5.6.1 Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.7 Baebies Inc Company Overview

5.7.1 Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.8 Beckman Coulter Inc Company Overview

5.8.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview

5.9 Beijing Sailing Medical Technology Co Ltd Company Overview

5.9.1 Beijing Sailing Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.10 Bio Vitos Pharma AB Company Overview

5.10.1 Bio Vitos Pharma AB Pipeline Products & Ongoing Clinical Trials Overview

5.11 Biochip Labs Inc Company Overview

5.11.1 Biochip Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

5.12 BioMedica USA LLC (Inactive) Company Overview

5.12.1 BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.13 BioMedomics Inc Company Overview

5.13.1 BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.14 Biosurfit, SA Company Overview

5.14.1 Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview

5.15 Braun Biosystems, Inc. (Inactive) Company Overview

5.15.1 Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.16 Carclo Diagnostic Solutions Ltd Company Overview

5.16.1 Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.17 Coramed Technologies, LLC Company Overview

5.17.1 Coramed Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.18 Diagnostica Stago Inc Company Overview

5.18.1 Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview

5.19 Duke University Company Overview

5.19.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview

5.20 DxDiscovery Inc Company Overview

5.20.1 DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview

5.21 Dynasil Corporation of America Company Overview

5.21.1 Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview

5.22 Edan Instruments Inc Company Overview

5.22.1 Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview

5.23 EKF Diagnostics Holdings Plc Company Overview

5.23.1 EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview

5.24 ELITechGroup Inc Company Overview

5.24.1 ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview

5.25 Emosis SAS Company Overview

5.25.1 Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview

5.26 Epimune GmbH Company Overview

5.26.1 Epimune GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.27 Epinex Diagnostics Inc Company Overview

5.27.1 Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.28 ET Healthcare Inc Company Overview

5.28.1 ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview

5.29 Flobio LLC Company Overview

5.29.1 Flobio LLC Pipeline Products & Ongoing Clinical Trials Overview

5.30 Fraunhofer Institute for Cell Therapy and Immunology Company Overview

5.30.1 Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview

5.31 genedrive plc Company Overview

5.31.1 genedrive plc Pipeline Products & Ongoing Clinical Trials Overview

5.32 Grifols SA Company Overview

5.32.1 Grifols SA Pipeline Products & Ongoing Clinical Trials Overview

5.33 Group K Diagnostics Company Overview

5.33.1 Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

5.34 Guangzhou Wondfo Biotech Co Ltd Company Overview

5.34.1 Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.35 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview

5.35.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview

5.36 Helena Laboratories Corp Company Overview

5.36.1 Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview

5.37 Hemex Health Inc Company Overview

5.37.1 Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview

5.38 HemoSonics LLC Company Overview

5.38.1 HemoSonics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.39 Immunostep S.L Company Overview

5.39.1 Immunostep S.L Pipeline Products & Ongoing Clinical Trials Overview

5.40 Instrumentation Laboratory Co (Inactive) Company Overview

5.40.1 Instrumentation Laboratory Co (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.41 IntraMed Diagnostics, LLC Company Overview

5.41.1 IntraMed Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview

5.42 Inverness Medical Canada Inc. (Inactive) Company Overview

5.42.1 Inverness Medical Canada Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.43 Levisonics Inc Company Overview

5.43.1 Levisonics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.44 Massachusetts General Hospital Company Overview

5.44.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

5.45 McMaster University Company Overview

5.45.1 McMaster University Pipeline Products & Ongoing Clinical Trials Overview

5.46 MiCo BioMed Co Ltd Company Overview

5.46.1 MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.47 Novametics Inc (Inactive) Company Overview

5.47.1 Novametics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.48 Ohio State University Company Overview

5.48.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview

5.49 Optolane Technologies Inc Company Overview

5.49.1 Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.50 Pakwa Technologies Company Overview

5.50.1 Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview

5.51 Perosphere Technologies Inc Company Overview

5.51.1 Perosphere Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

5.52 PortaScience Inc Company Overview

5.52.1 PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.53 Prolight Diagnostics AB Company Overview

5.53.1 Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

5.54 QSTAG Co Ltd Company Overview

5.54.1 QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.55 Radiometer Medical ApS Company Overview

5.55.1 Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview

5.56 Randox Laboratories Ltd Company Overview

5.56.1 Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.57 Rappaport Family Institute for Research in the Medical Science Company Overview

5.57.1 Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview

5.58 Retham Technologies LLC Company Overview

5.58.1 Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

5.59 rHealth Company Overview

5.59.1 rHealth Pipeline Products & Ongoing Clinical Trials Overview

5.60 Roche Diagnostics International Ltd Company Overview

5.60.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.61 Sanguina LLC Company Overview

5.61.1 Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview

5.62 Sekisui Diagnostics LLC Company Overview

5.62.1 Sekisui Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

5.63 ShanMukha Innovations Pvt Ltd Company Overview

5.63.1 ShanMukha Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.64 Siemens Healthcare Diagnostics GmbH Company Overview

5.64.1 Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview

5.65 Siemens Healthcare Diagnostics Inc Company Overview

5.65.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.66 Siemens Healthineers AG Company Overview

5.66.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview

5.67 Silver Lake Research Corporation Company Overview

5.67.1 Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview

5.68 SonoMedix, Inc. Company Overview

5.68.1 SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview

5.69 SpinChip Diagnostics AS Company Overview

5.69.1 SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview

5.70 SQI Diagnostics Inc Company Overview

5.70.1 SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.71 Stichting Lygature Company Overview

5.71.1 Stichting Lygature Pipeline Products & Ongoing Clinical Trials Overview

5.72 T2 Biosystems Inc Company Overview

5.72.1 T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview

5.73 The Binding Site Group Ltd Company Overview

5.73.1 The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

5.74 ThromboTherapeutics Inc Company Overview

5.74.1 ThromboTherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

5.75 Tosoh Bioscience Inc Company Overview

5.75.1 Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

5.76 Transfusion & Transplantation Technologies (Inactive) Company Overview

5.76.1 Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

5.77 Universal Biosensors Inc Company Overview

5.77.1 Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview

5.78 University of Burdwan Company Overview

5.78.1 University of Burdwan Pipeline Products & Ongoing Clinical Trials Overview

5.79 University of California Irvine Company Overview

5.79.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview

5.80 University of Colorado Company Overview

5.80.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

5.81 University of Colorado Anschutz Medical Campus Company Overview

5.81.1 University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview

5.82 University of Melbourne Company Overview

5.82.1 University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview

5.83 University of Michigan Company Overview

5.83.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

5.84 University of Texas Health Science Center at Houston Company Overview

5.84.1 University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview

5.85 University of Vermont Company Overview

5.85.1 University of Vermont Pipeline Products & Ongoing Clinical Trials Overview

5.86 University of Washington Company Overview

5.86.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview

5.87 VitaMe Technologies Inc Company Overview

5.87.1 VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

6 Hematological Disorders- Recent Developments

6.1 Oct 10, 2024: Provectus Biopharmaceuticals Announces Fourth Quarter 2024 Conference Call

6.2 Oct 08, 2024: T2 Biosystems to Host Business Update Call on October 10, 2024

6.3 Oct 07, 2024: Researchers Find Gazelle Hb Variant Test Offers Accuracy and Accessibility for Newborn Sickle Cell Disease Screening and Premarital Screening for Beta Thalassemia and Sickle Cell Disease

6.4 Oct 04, 2024: Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2024 on Monday, November 4, 2024

6.5 Oct 02, 2024: Quanterix Adds Ivana Magovcevic-Liebisch to Board of Directors

6.6 Oct 01, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024

6.7 Sep 30, 2024: Sysmex Launches “HISCL HIT IgG Assay Kit” Contributing to the Detection of Adverse Reactions to Heparin Therapy

6.8 Sep 25, 2024: Perosphere Technologies to Deliver Oral Presentation & Posters on Point-Of-Care Coagulometer at ADLM International Cpoct Symposium

6.9 Sep 17, 2024: The Results Of a Test Created In Barcelona For The Detection Of Multiple Cancers Are Presented at ESMO

6.10 Sep 09, 2024: Baxter Names Former Auto Exec Jay Craig to Its Board

6.11 Sep 03, 2024: New Machine Learning Models to Identify Driver Mutations for Clonal Hematopoiesis

6.12 Aug 28, 2024: WerfenLife Receives additional 510(k) clearance for ACL TOP 350 CTS Coagulation Analyzer

6.13 Aug 28, 2024: WerfenLife Receives additional 510(k) clearance for ACL TOP 550 CTS Coagulation Analyzer

6.14 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.15 Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

6.16 Aug 23, 2024: WerfenLife Receives additional 510(K) Clearance for ACL TOP 750 Coagulation Analyzer

6.17 Aug 23, 2024: WerfenLife Receives additional 510(K) Clearance for ACL TOP 750 CTS Coagulation Analyzer

6.18 Aug 23, 2024: WerfenLife Receives additional 510(K) Clearance for ACL TOP 750 LAS Coagulation Analyzer

6.19 Aug 21, 2024: Italy Tender Win for Xprecia Prime

6.20 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer

6.21 Aug 19, 2024: Jeffrey Elliott Appointed to Quanterix’s Board of Directors

6.22 Aug 13, 2024: Trinity Biotech to Announce Q2 2024 Financial Results

6.23 Jul 22, 2024: Relentless Health to Partner with Firefighters to Deliver PFAS Testing

6.24 Jul 17, 2024: Baxter to Host Second-Quarter 2024 Financial Results Conference Call for Investors

6.25 Jul 11, 2024: Perosphere Technologies and M3 Medical Sign Distribution Agreement for Point-Of-Care Coagulometer in Ireland

6.26 Jul 02, 2024: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, July 24, 2024

6.27 Jun 19, 2024: Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024

6.28 Jun 17, 2024: Thermo Fisher Scientific Showcases Clinical Research Innovation at DIA Annual Meeting

6.29 Jun 13, 2024: Medtronic Confirms Global Layoffs

6.30 Jun 07, 2024: Steve Knight Appointed Regional Sales Manager for Fire Products at Siemens

6.31 May 08, 2024: Biohit Notice of Annual General Meeting

6.32 May 07, 2024: Siemens Healthineers on Track to Meet Fiscal Year 2024 Targets After Second Quarter

6.33 May 07, 2024: Baxter to Present at Bank of America 2024 Health Care Conference

6.34 May 07, 2024: Quest Diagnostics to Speak at the 2024 Leerink Partners Healthcare Crossroads Conference

6.35 Apr 16, 2024: ADC Therapeutics Accelerates R&D with Genedata Biologics

6.36 Apr 13, 2024: HemoSonics Receives Additional FDA 510(k) Clearance for QStat Cartridge

6.37 Apr 03, 2024: FDA Grants HemoSonics Expanded Use of its Critical Bleeding Management System with Special 510(k) Clearance

6.38 Apr 03, 2024: PatientPoint Appoints Sean Slovenski as President to Drive Innovation and Growth

6.39 Apr 02, 2024: Siemens Healthineers Integrates Hemostasis Product Offerings in United States and Europe

6.40 Apr 02, 2024: Sysmex Begins Selling Hemostasis Instruments and Reagents Under the Sysmex Brand in the United States and EU Countries

6.41 Apr 02, 2024: Siemens Healthineers Integrates Hemostasis Product Offerings in United States and Europe

6.42 Apr 02, 2024: Soluble Immune Checkpoint Factors in Blood as Potential Biomarkers of Therapeutic Efficacy for ICI Cancer Immunotherapy and Assessing T-cell Exhaustion

6.43 Mar 22, 2024: Universal Biosensors Received FDA 510(K) Clearance For Xprecia Prime

6.44 Mar 19, 2024: Quest Diagnostics to Release First Quarter 2024 Financial Results on April 23, 2024

6.45 Mar 18, 2024: Siemens Healthineers Intends to Close Fast Track Diagnostics

6.46 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

6.47 Mar 10, 2024: Technoclone Herstellung von Diagnostika und Arzneimitteln Receives De Nova Clearance For Technozym ADAMTS13 Activity Assay

6.48 Mar 10, 2024: Technoclone Herstellung von Diagnostika und Arzneimitteln Received CLIA Approval For Technozym ADAMTS13 Activity Assay

6.49 Mar 05, 2024: Technoclone Receives US FDA Marketing Authorization for the First ADAMTS13 Activity Diagnostic Test

6.50 Feb 13, 2024: HemoSonics’ Quantra Hemostasis System Named as a Finalist in the World Renowned 2024 Edison Awards

6.51 Feb 13, 2024: Siemens Announces a 22% Increase in Revenue at 14% Pbt (As A % Of Revenue) In Q1 Fy 2024 Results

6.52 Feb 08, 2024: Siemens Announces Successful Start to Fiscal 2024

6.53 Feb 05, 2024: Study of First Affordable and Rapid Test for Beta Thalassemia Performs at 99% Accuracy in Diagnosing the Blood Disorder

6.54 Feb 01, 2024: Strengthening the Direct Sales and Service System for Business Expansion in Italy

6.55 Jan 17, 2024: Capitainer Opens New qDBS Microsampling Laboratory in Rhode Island, U.S.

6.56 Jan 08, 2024: Instrumentation Laboratory Receives Additional 510(K) Clearance For ACL TOP 970 CL Hemostasis Testing System

6.57 Jan 08, 2024: Joining hands to promote precise diagnosis and treatment of hematology diseases, Dean Diagnostics and Shanghai Ruijin Hematology Medical Alliance have reached a strategic cooperation

6.58 Jan 04, 2024: Hologic to Announce Financial Results for the First Quarter of Fiscal 2024 on Thursday, February 1, 2024

6.59 Jan 04, 2024: Baxter to Host Fourth-Quarter 2023 Financial Results Conference Call for Investors

6.60 Jan 02, 2024: Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference

6.61 Dec 26, 2023: Instrumentation Laboratory Receives 510(k) Clearance for HemosIL Chromogenic Factor IX Test

6.62 Nov 28, 2023: Thermo Fisher Scientific Prices Offering Of $2.5 Bln Of Senior Notes

6.63 Nov 27, 2023: Siemens Appoints Hakan Ozdemir as CEO of Smart Infrastructure in the Middle East

6.64 Nov 13, 2023: ARUP receives CE mark for AAV5 DetectCDx test

6.65 Oct 25, 2023: Sanguina Receives CLIA Approval For AnemoCheck Home

7 Appendix

7.1 Methodology

7.2 About GlobalData

7.3 Contact Us

7.4 Disclaimer

Table

Hematological Disorders – Pipeline Products by Stage of Development

Hematological Disorders – Pipeline Products by Segment

Hematological Disorders – Pipeline Products by Territory

Hematological Disorders – Pipeline Products by Regulatory Path

Hematological Disorders – Pipeline Products by Estimated Approval Date

Hematological Disorders – Ongoing Clinical Trials

Hematological Disorders Companies – Pipeline Products by Stage of Development

Hematological Disorders – Pipeline Products by Stage of Development

Abionic SA Pipeline Products & Ongoing Clinical Trials Overview

Point of Care Diagnostic Test – Basophils – Product Status

Point of Care Diagnostic Test – Basophils – Product Description

Point of Care Diagnostic Test – Eosinophils – Product Status

Point of Care Diagnostic Test – Eosinophils – Product Description

Point of Care Diagnostic Test – Erythrocyte – Product Status

Point of Care Diagnostic Test – Erythrocyte – Product Description

Point of Care Diagnostic Test – Hemoglobin – Product Status

Point of Care Diagnostic Test – Hemoglobin – Product Description

Point of Care Diagnostic Test – Lymphocytes – Product Status

Point of Care Diagnostic Test – Lymphocytes – Product Description

Point of Care Diagnostic Test – Neutrophils – Product Status

Point of Care Diagnostic Test – Neutrophils – Product Description

Point of Care Diagnostic Test – Thrombocytes – Product Status

Point of Care Diagnostic Test – Thrombocytes – Product Description

Point of Care Diagnostic Test – White Blood Cells – Product Status

Point of Care Diagnostic Test – White Blood Cells – Product Description

Abram Scientific Inc Pipeline Products & Ongoing Clinical Trials Overview

CoagCare System – Product Status

CoagCare System – Product Description

Analyticon Biotechnologies AG Pipeline Products & Ongoing Clinical Trials Overview

Coagulyzer 1 – Product Status

Coagulyzer 1 – Product Description

Coagulyzer 2 – Product Status

Coagulyzer 2 – Product Description

Coagulyzer 4 – Product Status

Coagulyzer 4 – Product Description

Aptitude Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview

POC Test – Trauma Coagulopathy – Product Status

POC Test – Trauma Coagulopathy – Product Description

Atantares Corp Pipeline Products & Ongoing Clinical Trials Overview

Platelet Function Assay – Product Status

Platelet Function Assay – Product Description

Atomo Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview

AtomoRapid – Coagulation Monitoring – Product Status

AtomoRapid – Coagulation Monitoring – Product Description

Baebies Inc Pipeline Products & Ongoing Clinical Trials Overview

Digital Microfluidic System – Trauma Coagulation – Product Status

Digital Microfluidic System – Trauma Coagulation – Product Description

Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview

SYNCHRON Lxi 725 D-Dimer Assay – Product Status

SYNCHRON Lxi 725 D-Dimer Assay – Product Description

Beijing Sailing Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Fourth-Generation Thromboelastogrpahy Device – Product Status

Fourth-Generation Thromboelastogrpahy Device – Product Description

Bio Vitos Pharma AB Pipeline Products & Ongoing Clinical Trials Overview

v-Test – Serum Tubes – Product Status

v-Test – Serum Tubes – Product Description

Biochip Labs Inc Pipeline Products & Ongoing Clinical Trials Overview

Endothelium-on-a-Chip Assay – Product Status

Endothelium-on-a-Chip Assay – Product Description

BioMedica USA LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Portable Diagnostic System – Hemostasis – Product Status

Portable Diagnostic System – Hemostasis – Product Description

BioMedomics Inc Pipeline Products & Ongoing Clinical Trials Overview

Fetomaternal Hemorrhage Test – Product Status

Fetomaternal Hemorrhage Test – Product Description

Hemo SCAN – Product Status

Hemo SCAN – Product Description

Hemo SCAN S – Product Status

Hemo SCAN S – Product Description

Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test – Product Status

Rapid Quantitative Heparin-Induced Thrombocytopenia (H.I.T.) Test – Product Description

Biosurfit, SA Pipeline Products & Ongoing Clinical Trials Overview

Spinit Device – Blood Quantitation Anemia Assay – Product Status

Spinit Device – Blood Quantitation Anemia Assay – Product Description

Spinit Device – Thrombocytopenia Assay – Product Status

Spinit Device – Thrombocytopenia Assay – Product Description

Braun Biosystems, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Bio6 – Product Status

Bio6 – Product Description

Carclo Diagnostic Solutions Ltd Pipeline Products & Ongoing Clinical Trials Overview

Micropoc-CAT – Haemostasis Assay – Product Status

Micropoc-CAT – Haemostasis Assay – Product Description

Coramed Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview

TEG 6000 Thrombelastograph – Product Status

TEG 6000 Thrombelastograph – Product Description

Diagnostica Stago Inc Pipeline Products & Ongoing Clinical Trials Overview

Calibrated Automated Thrombogram – Thrombin Assay – Product Status

Calibrated Automated Thrombogram – Thrombin Assay – Product Description

STA Compact Max – NeoPTimal ISI – Product Status

STA Compact Max – NeoPTimal ISI – Product Description

STA Compact Max – Ristocetin Cofactor Assay – Product Status

STA Compact Max – Ristocetin Cofactor Assay – Product Description

STA Compact Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Status

STA Compact Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Description

STA-R Evolution Expert – Automated Ecarin Chromogenic Assay – Product Status

STA-R Evolution Expert – Automated Ecarin Chromogenic Assay – Product Description

STA-R Evolution Plus – Automated Ecarin Chromogenic Assay – Product Status

STA-R Evolution Plus – Automated Ecarin Chromogenic Assay – Product Description

STA-R Evolution Plus – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa – Product Status

STA-R Evolution Plus – Rivaroxaban and Apixaban Calibrators And Controls For Anti-Xa – Product Description

STA-R Max – NeoPTimal ISI – Product Status

STA-R Max – NeoPTimal ISI – Product Description

STA-R Max – Ristocetin Cofactor Assay – Product Status

STA-R Max – Ristocetin Cofactor Assay – Product Description

STA-R Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Status

STA-R Max – Rivaroxaban Calibrators And Controls For Anti-Xa – Product Description

Duke University Pipeline Products & Ongoing Clinical Trials Overview

Handheld Impedimetric Coagulometer – PT/INR Measurement – Product Status

Handheld Impedimetric Coagulometer – PT/INR Measurement – Product Description

DxDiscovery Inc Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Sickle Cell Disease – Product Status

Diagnostic Assay – Sickle Cell Disease – Product Description

Dynasil Corporation of America Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Hemophilia – Product Status

Diagnostic Test – Hemophilia – Product Description

Edan Instruments Inc Pipeline Products & Ongoing Clinical Trials Overview

i15 – Coagulation Test – Product Status

i15 – Coagulation Test – Product Description

EKF Diagnostics Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview

Point-Of-Care Test – Coagulation – Product Status

Point-Of-Care Test – Coagulation – Product Description

ELITechGroup Inc Pipeline Products & Ongoing Clinical Trials Overview

Selectra ProM Chemistry System – D-dimer Assay – Product Status

Selectra ProM Chemistry System – D-dimer Assay – Product Description

Selectra ProS Chemistry System – D-dimer Assay – Product Status

Selectra ProS Chemistry System – D-dimer Assay – Product Description

Emosis SAS Pipeline Products & Ongoing Clinical Trials Overview

ClotSeek – Product Status

ClotSeek – Product Description

Epimune GmbH Pipeline Products & Ongoing Clinical Trials Overview

i.Mune Tbnk Test – Product Status

i.Mune Tbnk Test – Product Description

Epinex Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

Epinex SimplySure PT-INR Test – Product Status

Epinex SimplySure PT-INR Test – Product Description

ET Healthcare Inc Pipeline Products & Ongoing Clinical Trials Overview

Pylon Assay – D-Dimer – Product Status

Pylon Assay – D-Dimer – Product Description

Flobio LLC Pipeline Products & Ongoing Clinical Trials Overview

DOAC Diagnostic Assay – Product Status

DOAC Diagnostic Assay – Product Description

Fraunhofer Institute for Cell Therapy and Immunology Pipeline Products & Ongoing Clinical Trials Overview

Point-Of-Care Assay – Primary And Secondary Hemostasis – Product Status

Point-Of-Care Assay – Primary And Secondary Hemostasis – Product Description

genedrive plc Pipeline Products & Ongoing Clinical Trials Overview

Genedrive – Factor V Leiden – Product Status

Genedrive – Factor V Leiden – Product Description

Grifols SA Pipeline Products & Ongoing Clinical Trials Overview

Hemostasis Reagent Kit – DG-APTT Synth G-Fib L Human – Product Status

Hemostasis Reagent Kit – DG-APTT Synth G-Fib L Human – Product Description

Hemostasis Reagent Kit – DG-Latex D Dimer – Product Status

Hemostasis Reagent Kit – DG-Latex D Dimer – Product Description

Hemostasis Reagent Kit – DG-Latex VWF: Gp1b – Product Status

Hemostasis Reagent Kit – DG-Latex VWF: Gp1b – Product Description

Hemostasis Reagent Kit – DG-TT L Human – Product Status

Hemostasis Reagent Kit – DG-TT L Human – Product Description

Group K Diagnostics Pipeline Products & Ongoing Clinical Trials Overview

KromaHealth Kit – Complete Blood Count – Product Status

KromaHealth Kit – Complete Blood Count – Product Description

Guangzhou Wondfo Biotech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Accre Diagnostic Assay – FDP – Product Status

Accre Diagnostic Assay – FDP – Product Description

Accre Diagnostic Assay – PIC – Product Status

Accre Diagnostic Assay – PIC – Product Description

Accre Diagnostic Assay – t-PAIC – Product Status

Accre Diagnostic Assay – t-PAIC – Product Description

Accre Diagnostic Assay – TAT – Product Status

Accre Diagnostic Assay – TAT – Product Description

Accre Diagnostic Assay – TM – Product Status

Accre Diagnostic Assay – TM – Product Description

Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview

Hemostasis Monitoring Microfluidic Device – Product Status

Hemostasis Monitoring Microfluidic Device – Product Description

Helena Laboratories Corp Pipeline Products & Ongoing Clinical Trials Overview

Actalyke Mini II – APTT Test – Product Status

Actalyke Mini II – APTT Test – Product Description

Actalyke Mini II – LMWH Test – Product Status

Actalyke Mini II – LMWH Test – Product Description

Actalyke Mini II – PT Test – Product Status

Actalyke Mini II – PT Test – Product Description

Actalyke XL – APTT Test – Product Status

Actalyke XL – APTT Test – Product Description

Actalyke XL – Heparin Test – Product Status

Actalyke XL – Heparin Test – Product Description

Actalyke XL – LMWH Test – Product Status

Actalyke XL – LMWH Test – Product Description

Actalyke XL – PT Test – Product Status

Actalyke XL – PT Test – Product Description

AggRAM – Chromogenic Test – Product Status

AggRAM – Chromogenic Test – Product Description

AggRAM – HIT Test – Product Status

AggRAM – HIT Test – Product Description

AggRAM – Lumi Test – Product Status

AggRAM – Lumi Test – Product Description

Cascade Abrazo – c-ACT-LR – Product Status

Cascade Abrazo – c-ACT-LR – Product Description

Cascade Abrazo – Direct Oral Anticoagulants Test – Product Status

Cascade Abrazo – Direct Oral Anticoagulants Test – Product Description

Cascade Abrazo – Direct Thrombin Inhibitors – Product Status

Cascade Abrazo – Direct Thrombin Inhibitors – Product Description

Cascade Abrazo – Fibrinogen – Product Status

Cascade Abrazo – Fibrinogen – Product Description

Cascade Abrazo – Heparin Titration – Product Status

Cascade Abrazo – Heparin Titration – Product Description

Cascade Abrazo – LMWH – Product Status

Cascade Abrazo – LMWH – Product Description

Cascade Abrazo – Protamine Titration – Product Status

Cascade Abrazo – Protamine Titration – Product Description

Cascade Abrazo – PT-C – Product Status

Cascade Abrazo – PT-C – Product Description

Cascade Abrazo Analyzer – Product Status

Cascade Abrazo Analyzer – Product Description

Cascade M – DRVVT Test – Product Status

Cascade M – DRVVT Test – Product Description

Cascade M-4 – DRVVT Test – Product Status

Cascade M-4 – DRVVT Test – Product Description

Hemex Health Inc Pipeline Products & Ongoing Clinical Trials Overview

Gazelle Hb Variant Test – Product Status

Gazelle Hb Variant Test – Product Description

RHODA – Product Status

RHODA – Product Description

HemoSonics LLC Pipeline Products & Ongoing Clinical Trials Overview

HemoSonics Global Hemostasis Analyzer – Intensive Care – Product Status

HemoSonics Global Hemostasis Analyzer – Intensive Care – Product Description

HemoSonics Global Hemostasis Analyzer – Neurosurgery – Product Status

HemoSonics Global Hemostasis Analyzer – Neurosurgery – Product Description

HemoSonics Global Hemostasis Analyzer – Orthopedic Surgery – Product Status

HemoSonics Global Hemostasis Analyzer – Orthopedic Surgery – Product Description

HemoSonics Global Hemostasis Analyzer – Trauma – Product Status

HemoSonics Global Hemostasis Analyzer – Trauma – Product Description

HemoSonics Global Hemostasis Analyzer HS-GHA – Product Status

HemoSonics Global Hemostasis Analyzer HS-GHA – Product Description

Immunostep S.L Pipeline Products & Ongoing Clinical Trials Overview

Bmplex Hemodilution Test – Product Status

Bmplex Hemodilution Test – Product Description

Instrumentation Laboratory Co (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

HemosIL VWF-Ristocetin Cofactor Activity Assay – Product Status

HemosIL VWF-Ristocetin Cofactor Activity Assay – Product Description

IntraMed Diagnostics, LLC Pipeline Products & Ongoing Clinical Trials Overview

ProTrac Coagulation – Product Status

ProTrac Coagulation – Product Description

Inverness Medical Canada Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Afinion PT Test – Capillary Blood – Product Status

Afinion PT Test – Capillary Blood – Product Description

Levisonics Inc Pipeline Products & Ongoing Clinical Trials Overview

Blood Coagulation Analyzer – Product Status

Blood Coagulation Analyzer – Product Description

Pediatric Coagulation Analyzer – Product Status

Pediatric Coagulation Analyzer – Product Description

Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview

High Throughput Screening Assay – Fibrin-Binding Probes – Product Status

High Throughput Screening Assay – Fibrin-Binding Probes – Product Description

McMaster University Pipeline Products & Ongoing Clinical Trials Overview

aFXa DOAC Assay – Product Status

aFXa DOAC Assay – Product Description

MiCo BioMed Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Labchip Based Test – Hemoglobin – Product Status

Labchip Based Test – Hemoglobin – Product Description

Novametics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Blood Coagulation Diagnostic Assay – Product Status

Blood Coagulation Diagnostic Assay – Product Description

Ohio State University Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Thrombotic Thrombocytopenic Purpura – Product Status

Diagnostic Assay – Thrombotic Thrombocytopenic Purpura – Product Description

Optolane Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Molecular Dx – Thrombosis Panel – Product Status

Molecular Dx – Thrombosis Panel – Product Description

Pakwa Technologies Pipeline Products & Ongoing Clinical Trials Overview

Platelet ActiSense – Product Status

Platelet ActiSense – Product Description

Perosphere Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

ClotChek – Product Status

ClotChek – Product Description

Perosphere Technologies Inc – Ongoing Clinical Trials Overview

ClotChek – A Phase 2 Randomized, Double-blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Ciraparantag for Reversal of Anticoagulation in Healthy Adults

ClotChek – Multi-site Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times of Patients on Anticoagulants and Verification of Measurement Precision of Liquid Quality Controls with the Perosphere Technologies’ PoC Coagulometer

ClotChek – Study for Evaluation of Clinical Ranges of Whole Blood Clotting Times

PortaScience Inc Pipeline Products & Ongoing Clinical Trials Overview

PortaPT – Product Status

PortaPT – Product Description

PortaWBC – Product Status

PortaWBC – Product Description

Prolight Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview

Point Of Care D-Dimer Test – Product Status

Point Of Care D-Dimer Test – Product Description

QSTAG Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

Qscheck – BISNUTRA Kit – Product Status

Qscheck – BISNUTRA Kit – Product Description

Radiometer Medical ApS Pipeline Products & Ongoing Clinical Trials Overview

AQT90 FLEX – APTT Test – Product Status

AQT90 FLEX – APTT Test – Product Description

AQT90 FLEX – PT-INR Test – Product Status

AQT90 FLEX – PT-INR Test – Product Description

Randox Laboratories Ltd Pipeline Products & Ongoing Clinical Trials Overview

Rx Daytona – D-dimer Assay – Product Status

Rx Daytona – D-dimer Assay – Product Description

Rx Imola D-dimer Test – Product Status

Rx Imola D-dimer Test – Product Description

Rappaport Family Institute for Research in the Medical Science Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Kit – Hypercoagulation – Product Status

Diagnostic Kit – Hypercoagulation – Product Description

Retham Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview

HITDx – Product Status

HITDx – Product Description

rHealth Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Test – Thrombocytopenia – Product Status

Diagnostic Test – Thrombocytopenia – Product Description

Fluorogenic FVIII Assay Kit – Product Status

Fluorogenic FVIII Assay Kit – Product Description

rHEALTH Coagulation Assay – Product Status

rHEALTH Coagulation Assay – Product Description

Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview

Cobas t 511 Coagulation Analyzer – dRVVT Confirm Assay – Product Status

Cobas t 511 Coagulation Analyzer – dRVVT Confirm Assay – Product Description

Cobas t 511 Coagulation Analyzer – dRVVT Screen Assay – Product Status

Cobas t 511 Coagulation Analyzer – dRVVT Screen Assay – Product Description

Cobas t 711 Coagulation Analyzer – APCr Assay – Product Status

Cobas t 711 Coagulation Analyzer – APCr Assay – Product Description

Cobas t 711 Coagulation Analyzer – dRVVT Confirm Assay – Product Status

Cobas t 711 Coagulation Analyzer – dRVVT Confirm Assay – Product Description

Cobas t 711 Coagulation Analyzer – dRVVT Screen Assay – Product Status

Cobas t 711 Coagulation Analyzer – dRVVT Screen Assay – Product Description

Cobas t 711 Coagulation Analyzer – FXIII Assay – Product Status

Cobas t 711 Coagulation Analyzer – FXIII Assay – Product Description

Sanguina LLC Pipeline Products & Ongoing Clinical Trials Overview

AnemoCheck Home – Product Status

AnemoCheck Home – Product Description

Sekisui Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview

Coapresta 2000 Chromogenic Assay – APL – Product Status

Coapresta 2000 Chromogenic Assay – APL – Product Description

Coapresta 2000 Chromogenic Assay – Heparin – Product Status

Coapresta 2000 Chromogenic Assay – Heparin – Product Description

Coapresta 2000 Chromogenic Assay – PLG – Product Status

Coapresta 2000 Chromogenic Assay – PLG – Product Description

Coapresta 2000 Clotting Time Assay – Factor XII – Product Status

Coapresta 2000 Clotting Time Assay – Factor XII – Product Description

Coapresta 2000 Clotting Time Assay – PC – Product Status

Coapresta 2000 Clotting Time Assay – PC – Product Description

Coapresta 2000 Latex Turbidimetry Assay – SF – Product Status

Coapresta 2000 Latex Turbidimetry Assay – SF – Product Description

ShanMukha Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

SickleFind – Product Status

SickleFind – Product Description

Siemens Healthcare Diagnostics GmbH Pipeline Products & Ongoing Clinical Trials Overview

Atellica COAG 360 System – ADP – Product Status

Atellica COAG 360 System – ADP – Product Description

Atellica COAG 360 System – Arachidonic Acid Reagent – Product Status

Atellica COAG 360 System – Arachidonic Acid Reagent – Product Description

Atellica COAG 360 System – Berichrom C-1 Inhibitor Assay – Product Status

Atellica COAG 360 System – Berichrom C-1 Inhibitor Assay – Product Description

Atellica COAG 360 System – Collagen Reagent – Product Status

Atellica COAG 360 System – Collagen Reagent – Product Description

Atellica COAG 360 System – Epinephrine Reagent – Product Status

Atellica COAG 360 System – Epinephrine Reagent – Product Description

Atellica COAG 360 System – Lyophilized Platelets Reagent – Product Status

Atellica COAG 360 System – Lyophilized Platelets Reagent – Product Description

Atellica COAG 360 System – N Antiserum to Human Antithrombin III Assay – Product Status

Atellica COAG 360 System – N Antiserum to Human Antithrombin III Assay – Product Description

Atellica COAG 360 System – N Antiserum to Human C1 Inhibitor Assay – Product Status

Atellica COAG 360 System – N Antiserum to Human C1 Inhibitor Assay – Product Description

Atellica COAG 360 System – N Antiserum To Human Fibrinogen Assay – Product Status

Atellica COAG 360 System – N Antiserum To Human Fibrinogen Assay – Product Description

Atellica COAG 360 System – N Antiserum to Human Plasminogen Assay – Product Status

Atellica COAG 360 System – N Antiserum to Human Plasminogen Assay – Product Description

Atellica COAG 360 System – Protein S Ac Assay – Product Status

Atellica COAG 360 System – Protein S Ac Assay – Product Description

Atellica COAG 360 System – Ristocetin Reagent – Product Status

Atellica COAG 360 System – Ristocetin Reagent – Product Description

Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

ADVIA 120 Hematology System – IRF Test – Product Status

ADVIA 120 Hematology System – IRF Test – Product Description

ADVIA 120 Hematology System – MPC Test – Product Status

ADVIA 120 Hematology System – MPC Test – Product Description

ADVIA 120 Hematology System – MPM Test – Product Status

ADVIA 120 Hematology System – MPM Test – Product Description

ADVIA 2120 Hematology System – MPC Test – Product Status

ADVIA 2120 Hematology System – MPC Test – Product Description

ADVIA 2120 Hematology System – MPM Test – Product Status

ADVIA 2120 Hematology System – MPM Test – Product Description

ADVIA 2120i Hematology System – MPC Test – Product Status

ADVIA 2120i Hematology System – MPC Test – Product Description

ADVIA 2120i Hematology System – MPM Test – Product Status

ADVIA 2120i Hematology System – MPM Test – Product Description

ADVIA Centaur XP Immunoassay System – D-Dimer Assay – Product Status

ADVIA Centaur XP Immunoassay System – D-Dimer Assay – Product Description

Sysmex CS-2000i System – Multifibren U Assay – Product Status

Sysmex CS-2000i System – Multifibren U Assay – Product Description

Sysmex CS-2100i System – Multifibren U Assay – Product Status

Sysmex CS-2100i System – Multifibren U Assay – Product Description

Sysmex CS-2500 System – Von Willebrand Factor Test – Product Status

Sysmex CS-2500 System – Von Willebrand Factor Test – Product Description

Sysmex CS-5100 System – Von Willebrand Factor Assay – Product Status

Sysmex CS-5100 System – Von Willebrand Factor Assay – Product Description

Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview

IMMULITE 1000 System – D-Dimer Assay – Product Status

IMMULITE 1000 System – D-Dimer Assay – Product Description

IMMULITE 1000 System – Turbo D-Dimer Assay – Product Status

IMMULITE 1000 System – Turbo D-Dimer Assay – Product Description

Sysmex CA-1500 – Innovance VWF Activity Assay – Product Status

Sysmex CA-1500 – Innovance VWF Activity Assay – Product Description

Sysmex CA-1500 – PT Multicalibrators Assay – Product Status

Sysmex CA-1500 – PT Multicalibrators Assay – Product Description

Sysmex CA-530 – PT Multicalibrators Assay – Product Status

Sysmex CA-530 – PT Multicalibrators Assay – Product Description

Sysmex CA-560 – Innovance VWF Activity Assay – Product Status

Sysmex CA-560 – Innovance VWF Activity Assay – Product Description

Sysmex CA-560 – PT Multicalibrators Assay – Product Status

Sysmex CA-560 – PT Multicalibrators Assay – Product Description

Sysmex CA-7000 – Innovance VWF Activity Assay – Product Status

Sysmex CA-7000 – Innovance VWF Activity Assay – Product Description

Sysmex CA-7000 – PT Multicalibrators Assay – Product Status

Sysmex CA-7000 – PT Multicalibrators Assay – Product Description

Silver Lake Research Corporation Pipeline Products & Ongoing Clinical Trials Overview

HemoTypeBT – Product Status

HemoTypeBT – Product Description

SonoMedix, Inc. Pipeline Products & Ongoing Clinical Trials Overview

NanoAcoustic Blood Analyzer – Product Status

NanoAcoustic Blood Analyzer – Product Description

SpinChip Diagnostics AS Pipeline Products & Ongoing Clinical Trials Overview

D-Dimer Assay – Product Status

D-Dimer Assay – Product Description

SpinChip – APTT Assay – Product Status

SpinChip – APTT Assay – Product Description

SpinChip – PT Assay – Product Status

SpinChip – PT Assay – Product Description

SQI Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview

IgXPlex – HIT Assay – Product Status

IgXPlex – HIT Assay – Product Description

Stichting Lygature Pipeline Products & Ongoing Clinical Trials Overview

Acute Marker Assay – Product Status

Acute Marker Assay – Product Description

Blood Capacity Assay – Product Status

Blood Capacity Assay – Product Description

T2 Biosystems Inc Pipeline Products & Ongoing Clinical Trials Overview

T2HemoStat – Product Status

T2HemoStat – Product Description

T2MR Assay – Platelet Function Testing – Product Status

T2MR Assay – Platelet Function Testing – Product Description

The Binding Site Group Ltd Pipeline Products & Ongoing Clinical Trials Overview

Optilite – Fibrinogen Assay – Product Status

Optilite – Fibrinogen Assay – Product Description

ThromboTherapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview

tPA-Challenge Assay – Product Status

tPA-Challenge Assay – Product Description

Tosoh Bioscience Inc Pipeline Products & Ongoing Clinical Trials Overview

AIA-1800 – D-dimer Test – Product Status

AIA-1800 – D-dimer Test – Product Description

AIA-600 II – D-dimer Test – Product Status

AIA-600 II – D-dimer Test – Product Description

Transfusion & Transplantation Technologies (Inactive) Pipeline Products & Ongoing Clinical Trials Overview

Aegis – DIC Assay – Product Status

Aegis – DIC Assay – Product Description

Universal Biosensors Inc Pipeline Products & Ongoing Clinical Trials Overview

Handheld POC Coagulation Testing System – Ambulatory Care – Product Status

Handheld POC Coagulation Testing System – Ambulatory Care – Product Description

Immunoassay Test – D-Dimer – Product Status

Immunoassay Test – D-Dimer – Product Description

University of Burdwan Pipeline Products & Ongoing Clinical Trials Overview

Hemoglobinopathy – Thalassemia Carrier Screening Kit – Product Status

Hemoglobinopathy – Thalassemia Carrier Screening Kit – Product Description

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Tool – Blood Coagulation – Product Status

Diagnostic Tool – Blood Coagulation – Product Description

University of Colorado Pipeline Products & Ongoing Clinical Trials Overview

Thrombelastography Assay – Product Status

Thrombelastography Assay – Product Description

University of Colorado Anschutz Medical Campus Pipeline Products & Ongoing Clinical Trials Overview

Traumatic Bleeding Detection Assay – Product Status

Traumatic Bleeding Detection Assay – Product Description

University of Melbourne Pipeline Products & Ongoing Clinical Trials Overview

Thrombin Generation Assay – Product Status

Thrombin Generation Assay – Product Description

University of Michigan Pipeline Products & Ongoing Clinical Trials Overview

mHemoRetractoMeter – Product Status

mHemoRetractoMeter – Product Description

University of Texas Health Science Center at Houston Pipeline Products & Ongoing Clinical Trials Overview

MEMS Based Blood Coagulometer – Product Status

MEMS Based Blood Coagulometer – Product Description

University of Vermont Pipeline Products & Ongoing Clinical Trials Overview

Diagnostic Assay – Hemophilia – Product Status

Diagnostic Assay – Hemophilia – Product Description

University of Washington Pipeline Products & Ongoing Clinical Trials Overview

Blood-Clotting Test – Product Status

Blood-Clotting Test – Product Description

VitaMe Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

Iron.Scan – Product Status

Iron.Scan – Product Description

Glossary

Figures

Hematological Disorders – Pipeline Products by Stage of Development

Hematological Disorders – Pipeline Products by Segment

Hematological Disorders – Pipeline Products by Territory

Hematological Disorders – Pipeline Products by Regulatory Path

Hematological Disorders – Pipeline Products by Estimated Approval Date

Hematological Disorders – Ongoing Clinical Trials

Frequently asked questions

Hematological Disorders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies standard reports
Currency USD
$4,000

Can be used by individual purchaser only

$12,000

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Hematological Disorders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hematological Disorders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies in real time.

  • Access a live Hematological Disorders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.